| Related Articles |
StatPearls
Book. 2018 01
Authors:
Abstract
Methylphenidate is FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults and as a second-line treatment for narcolepsy in adults. Children with a diagnosis of ADHD should be at least six years of age or older before being started on this medication. The treatment of both ADHD and narcolepsy have significantly better outcomes when used concurrently with nonpharmacologic treatments (i.e., social skills training in ADHD or sleep hygiene measures in narcolepsy).
PMID: 29494058
via https://www.ncbi.nlm.nih.gov/pubmed/29494058?dopt=Abstract